Integra Lowers FY26 Forecast Following Cincinnati Flood; Plans $600M Debt Refinance
Integra LifeSciences (IART) cut its FY26 adjusted EPS and revenue forecast due to Cincinnati flood damage, now expecting $2.30-$2.40 EPS and $1.634B-$1.654B revenue. Q3 revenue is estimated to be $410M-$412M. The company plans a $600M debt refinancing to extend maturities and maintain flexibility.
How this was made
The 30-second read
Why it matters
The guidance downgrade and debt issuance are fresh disclosures that directly affect valuation and credit metrics.
Market read
The news provides a clear, actionable catalyst for IART traders, with immediate price impact expected in pre‑market trading.
What to watch
Potential insurance recoveries and the timing of full plant restoration in Q2 2027 could mitigate the revenue shortfall.
Background
Integra LifeSciences reported that July flooding at its Cincinnati plant reduced Q3 revenue by $7M and is expected to cut Q4 revenue by $15‑$20M. The company is launching a $600M senior secured term loan to refinance existing debt.
Ticker impact
Integra LifeSciences cut FY26 adjusted EPS guidance to $2.30‑$2.40 and announced a $600M senior secured term loan refinancing.
likely downward pressure as investors price in weaker earnings outlook and higher debt load
The company lowered EPS guidance by $0.10‑$0.20 and disclosed a sizable $600M loan, both fresh facts that typically trigger sell‑side reaction.
Market effects
Medical device and specialty pharma peers may see modest valuation pressure as the guidance cut highlights sector exposure to flood‑related disruptions.
U.S. markets may open lower on the news, especially health‑care indices.
Limited; impact confined to U.S. listed health‑care stocks.
Counterpoint
If the flood impact is short‑lived and the refinancing improves balance‑sheet flexibility, the stock could rebound on the back of a stronger capital structure.
Key entities
- companyIntegra LifeSciences Holdings Corp.
U.S. medical device and specialty pharma company (ticker IART) reporting FY26 guidance cut and debt refinancing.
